Holen Sie sich die Stockscreener-App
36.43
1.19%
-0.44
Handel nachbörslich:
36.43
Lineage Inc Aktie (LINE) Neueste Nachrichten
Lineage raises quarterly dividend by 1% to $0.5325/share - MSN
Lineage, Inc. Declares Increased Dividend for First-Quarter 2026 - The Joplin Globe
Insider Buying: Brian Culley Acquires 15,000 Shares of Lineage C - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Encourages Lineage, Inc. (LINE) Investors to Inquire about Securities Investigation - ACCESS Newswire
Lineage, Inc. $LINE Shares Sold by Quantbot Technologies LP - MarketBeat
Top Lineage Insider Makes Bold New Move With Fresh Share Purchase - TipRanks
Capital Research Global Investors Buys 120,616 Shares of Lineage, Inc. $LINE - MarketBeat
Lineage Inc (LINE) Stock Price Down 4.46% on Mar 12 - GuruFocus
Kevin Patrick Marchetti Buys 11,222 Shares of Lineage (NASDAQ:LINE) Stock - MarketBeat
Lineage (LINE) Sees Price Target Raised By Scotiabank | LINE Sto - GuruFocus
Lineage Cell Therapeutics, Inc. Files Form 8-K for At-The-Market Offering – Key Company and Security Information (LCTX, NYSEAMER) 232425 - Minichart
Lineage Cell Therapeutics files prospectus supplement for up to $60 million share offering - Investing.com
Lineage Therap Expands ATM Equity Offering Capacity - TipRanks
West Liberty, Lineage team up on sandwich distribution facility - MEAT+POULTRY
Scotiabank raises Lineage stock price target on cold storage outlook By Investing.com - Investing.com South Africa
Scotiabank raises Lineage stock price target on cold storage outlook - Investing.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lineage, Inc. (LINE) And Encourages Investors to Reach Out - ACCESS Newswire
Lineage, Inc. $LINE Shares Acquired by Barclays PLC - MarketBeat
Lineage (LINE) Price Target Increased to $44 by RBC Capital on Q4 FFO Strength - Finviz
US Market Wrap: Is Klotho Neurosciences Inc gaining market shareGap Down & Daily Technical Forecast Reports - baoquankhu1.vn
Lineage Inc (LINE) Stock Price Down 3.87% on Mar 9 - GuruFocus
H.C. Wainwright Maintains Buy on Lineage Cell Therapeutics (LCTX) Mar 2026 - Meyka
2026-03-08 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lineage, Inc. (LINE) And Encourages Stockholders to Reach Out | NDAQ:LINE | Press Release - Stockhouse
Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q4 2025 Earnings Call Transcript - Insider Monkey
Why Lineage Cell Therapeutics Inc. stock could outperform in 2026Portfolio Performance Summary & Free Verified High Yield Trade Plans - Naître et grandir
Lineage, Inc. Earnings Call Balances Progress And Pressure - The Globe and Mail
Can Lineage Cell Therapeutics Inc. stock resist market sell offsQuarterly Growth Report & Long Hold Capital Preservation Plans - Naître et grandir
Lineage Inc (LINE) Trading Down 3.24% on Mar 6 - GuruFocus
Lineage Cell Therapeutics, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides B - PharmiWeb.com
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - Business Wire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lineage, Inc. (LINE) And Encourages Stockholders to Connect - ACCESS Newswire
Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 5, 2026 - Investing News Network
LINE PE Ratio & Valuation, Is LINE Overvalued - Intellectia AI
LCTX SEC FilingsLineage Cell The 10-K, 10-Q, 8-K Forms - Stock Titan
A Look Ahead: Lineage Cell Therapeutics's Earnings Forecast - Benzinga
Lineage (LINE) Is Up 5.1% After Returning to Quarterly Profitability on Flat SalesWhat's Changed - simplywall.st
Analysts Offer Insights on Real Estate Companies: Equity Residential (EQR) and Lineage, Inc. (LINE) - The Globe and Mail
LINE Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
LINE (NASDAQ: LINE) Form 144 notice: proposed sale of 7,983 shares - Stock Titan
Lineage Point Capital discloses 1.1M shares in TGE Value (BEBE) - Stock Titan
Lineage, Inc. (LINE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Assessing Lineage (NasdaqGS:LINE) Valuation After Q4 Profit Swing And Narrowed Annual Net Loss - simplywall.st
Wells Fargo & Company Forecasts Strong Price Appreciation for Lineage (NASDAQ:LINE) Stock - MarketBeat
Lineage (LINE) Price Target Raised by Wells Fargo to USD 39 | LI - GuruFocus
RBC Raises Price Target on Lineage to $44 From $42, Keeps Outperform Rating - marketscreener.com
Waterfall Asset Management LLC Invests $6.28 Million in Lineage, Inc. $LINE - MarketBeat
Lineage: Cold Storage REIT Still Undervalued Thanks To Near-Term Headwinds (NASDAQ:LINE) - Seeking Alpha
Lineage Cell Therapeutics IncWithdrew CIRM Grant Application Filed In June 2025SEC Filing - TradingView
Artisan Partners Limited Partnership Trims Stock Position in Lineage, Inc. $LINE - MarketBeat
Panic Selling: Is Lineage Inc benefiting from innovation trendsMarket Activity Report & Reliable Trade Execution Plans - baoquankhu1.vn
Is It Time To Reassess Lineage (LINE) After Recent Real Estate Sector Rethink? - simplywall.st
LINE Investors Have Opportunity to Join Lineage, Inc. Fraud Investigation With the DJS Law Group - 富途牛牛
Lineage (NASDAQ:LINE) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat
LCTX PE Ratio & Valuation, Is LCTX Overvalued - Intellectia AI
Lineage (LINE) Stock Target Price Raised by Piper Sandler | LINE - GuruFocus
Analysts Offer Insights on Real Estate Companies: Lineage, Inc. (LINE) and Pebblebrook Hotel (PEB) - The Globe and Mail
Greg Lehmkuhl: Strategic Logistics Leader, Lineage President and CEO, and Pioneer in Global Cold Chain Transformation - BBN Times
What 7 Analyst Ratings Have To Say About Lineage - Benzinga
Maintaining a Buy on Lineage, Inc.: Operational Discipline and Cost Efficiencies Support 2026 Outlook Amid Macro Headwinds - TipRanks
1.12%
1.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):